Navigation Links
Stereotaxis Announces Fourth Quarter and Full Year 2008 Earnings Release Date and Conference Call
Date:2/6/2009

ST. LOUIS, Feb. 6 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that it will release its financial results for the fourth quarter and full year ended December 31, 2008, on Thursday, February 26, 2009 before the market opens. The Company will host a conference call and webcast on Thursday, February 26, 2009 at 8:30 a.m. Eastern Time to discuss the Company's fourth quarter results and current corporate developments. The dial-in number for the conference call is 800-240-2134 for domestic participants and 303-275-2170 for international participants.

A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days. This replay can be accessed by dialing 800-405-2236 for domestic callers and 303-590-3000 for international callers, both using passcode 11125670#. The call will also be available on the Internet live and 90 days thereafter at the following URL: http://www.videonewswire.com/event.asp?id=55849

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe and Canada.


'/>"/>
SOURCE Stereotaxis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Stereotaxis Showcases Advancements for Remote Magnetic Ablations
2. Stereotaxis Appoints Senior Vice President, North America
3. Stereotaxis to Present at the Seventh Annual JMP Securities Research Conference
4. Stereotaxis Market Leadership Highlighted at Heart Rhythm 2008
5. Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey(TM) Network
6. Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results
7. Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer
8. Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter
9. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
10. Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
11. Hoya Announces Third Quarter and the First Nine Months Financial Results for FY2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... MYOLYN, which creates medical technology ... a 510(k) to the FDA, requesting clearance of the MyoCycle Home and the ... technology. , The submission marks a major milestone for the technology startup. ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... 2017, to sell research and genetic testing lab equipment from two different leading institutes. ... Northwest and Northeast regions of the United States. This 1-day online auction will ...
(Date:1/18/2017)... Shareholder rights law firm Johnson & Weaver, ... members of CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD ... proposed sale of the Company to Eli Lilly and ... molecules for the acute treatment of migraines. ... a definitive merger agreement with Eli Lilly. Under the ...
(Date:1/18/2017)... TORONTO , Jan. 18, 2017 /PRNewswire/ - ... life sciences and diagnostics company that develops and ... diagnostics ("SQI" or the "Company"), today announced that ... Markets Inc. ("Kingsdale"), has resigned from its Board ... recent changes to securities regulations that have limited ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, Inc., ... in healthy volunteers of a novel calcium release-activated ... acute pancreatitis. Acute pancreatitis, sudden ... mild disorder, but can be very serious.  In severe ... sepsis, where extended hospital stays, time in the ...
(Date:1/4/2017)... 2017  For the thousands of attendees at this year,s International Consumer ... health and biometric measurement devices and services, will be featuring its new ... in A&D Medical,s special CES Exhibit Suite , the new upper ... the company,s WellnessConnected product platform.  ... ...
(Date:12/22/2016)... MOUNTAIN VIEW, Calif. , Dec. 20, 2016  As ... all levels, 23andMe, the leading personal genetics company, recently released ... Only Me . The book focuses on the topics ... the Next Generation Science Standards (NGSS) taught in elementary school ... the second in a series by illustrator Ariana Killoran ...
Breaking Biology News(10 mins):